ArticleFrontiers in oncology2022

Effectiveness and Cost-Utility Analysis of Different Doses of Irinotecan Plus Bevacizumab in Patients With Metastatic Colorectal Cancer: A Long-Term and Prospective Cohort Study.

Hon-Yi Shi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.